Free Trial
→ Tesla. SolarCity. Twitter. This $4 stock is next. (From Behind the Markets) (Ad)tc pixel Free SLS Stock Alerts

SELLAS Life Sciences Group (SLS) Short Interest Ratio & Short Volume

SELLAS Life Sciences Group logo
$7.83 +0.08 (+1.03%)
Closing price 04:00 PM Eastern
Extended Trading
$7.94 +0.11 (+1.46%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

SELLAS Life Sciences Group Short Interest Overview

As of May 29, 2026, SELLAS Life Sciences Group (SLS) had a short interest of 61.00 million shares sold short, representing 31.43% of the public float. This marks a 6.89% increase in short interest since the prior report. The short interest ratio (days to cover) is 4.4, meaning it would take 4.4 days of the average trading volume of 10.00 million shares to cover all short positions.

Current Short Interest
61,000,107 shares
Previous Short Interest
57,070,692 shares
Change Vs. Previous Month
6.89%
Dollar Volume Sold Short
$567.91 million
Short Interest Ratio
4.4 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
196,630,000 shares
Short Percent of Float
31.43%
Today's Trading Volume
4,059,128 shares
Average Trading Volume
9,996,583 shares
Today's Volume Vs. Average
41%
Short Selling SELLAS Life Sciences Group?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

SLS Short Interest Over Time

SLS Days to Cover Over Time

SLS Percentage of Float Shorted Over Time

SELLAS Life Sciences Group Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/202661,000,107 shares $567.91 million +6.9%31.4%4.42 $9.31
5/15/202657,070,692 shares $404.06 million -0.1%31.1%7.14 $7.08
4/30/202657,147,188 shares $282.88 million +0.9%31.3%11.68 $4.95
4/15/202656,642,215 shares $278.11 million +5.8%32.0%13.63 $4.91
3/31/202653,525,042 shares $226.41 million +16.9%30.2%5.96 $4.23
3/13/202645,790,317 shares $245.89 million -6.8%32.5%6.25 $5.37
2/27/202649,129,452 shares $242.21 million +6.7%34.9%7.79 $4.93
2/13/202646,050,545 shares $165.32 million +11.4%32.7%10.01 $3.59
1/30/202641,330,037 shares $155.81 million -1.7%29.4%6.26 $3.77
1/15/202642,044,430 shares $161.45 million -14.9%29.9%2.59 $3.84
12/31/202549,429,420 shares $186.35 million +22.2%35.1%4.31 $3.77
12/15/202540,466,622 shares $82.55 million +21.7%28.8%7.07 $2.04
11/28/202533,260,681 shares $53.72 million +4.6%23.6%10.24 $1.62
11/14/202531,792,641 shares $45.46 million +9.8%25.8%8.9 $1.43
10/31/202528,964,581 shares $52.72 million +15.4%23.5%4.73 $1.82
10/15/202525,090,000 shares $54.70 million +8.9%20.3%9 $2.18
9/30/202523,050,000 shares $37.11 million +10.3%N/A10.3 $1.61
9/15/202520,890,000 shares $35.10 million -28.8%N/A8.1 $1.68
8/31/202529,340,000 shares $56.33 million +0.7%28.3%11.4 $1.92
8/15/202529,150,000 shares $47.51 million +10.4%N/A10.7 $1.63
7/31/202526,410,000 shares $41.99 million -4.8%26.8%9.1 $1.59
7/15/202527,740,000 shares $52.71 million +13.9%N/A9.1 $1.90
6/30/202524,360,000 shares $53.35 million +28.9%24.8%8.8 $2.19
6/15/202518,900,000 shares $31.37 million +54.7%19.2%8.6 $1.66
5/31/202512,220,000 shares $20.65 million +39.5%17.6%6.4 $1.69
5/15/20258,760,000 shares $14.02 million +13.6%12.6%5.1 $1.60
4/30/20257,710,000 shares $11.95 million -0.8%N/A5.4 $1.55
4/15/20257,770,000 shares $10.02 million -5.0%11.2%3.2 $1.29
3/31/20258,180,000 shares $8.83 million +4.2%11.8%3.3 $1.08
3/15/20257,850,000 shares $8.95 million +0.5%11.3%3.2 $1.14
2/28/20257,810,000 shares $9.22 million -9.7%11.2%2.9 $1.18
2/15/20258,650,000 shares $11.42 million -11.8%12.4%3.2 $1.32
1/31/20259,810,000 shares $15.89 million +9.0%N/A3.7 $1.62
1/15/20259,000,000 shares $8.73 million +12.9%N/A4.4 $0.97
12/31/20247,970,000 shares $8.29 million +6.8%N/A7 $1.04
12/15/20247,460,000 shares $6.51 million -17.6%N/A7.6 $0.87
11/30/20249,050,000 shares $10.23 million +3.2%N/A11.2 $1.13
11/15/20248,770,000 shares $11.58 million +1.9%N/A14.3 $1.32
10/31/20248,610,000 shares $10.16 million +41.6%N/A16.1 $1.18
10/15/20246,080,000 shares $7.30 million -25.7%N/A10.2 $1.20
Goldman Sachs just told you what to buy (most people missed it) (Ad)

Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free.tc pixel

See the stock positioned to solve AI's biggest power crisis
9/30/20248,180,000 shares $10.23 million +0.3%N/A13 $1.25
9/15/20248,160,000 shares $10.77 million -0.7%N/A12.4 $1.32
8/31/20248,220,000 shares $10.60 million +6.5%N/A9.2 $1.29
8/15/20247,720,000 shares $9.80 million -27.5%N/A8.4 $1.27
7/31/202410,650,000 shares $12.35 million +9.6%N/A11 $1.16
7/15/20249,720,000 shares $10.59 million +9.7%N/A8.3 $1.09
6/30/20248,860,000 shares $10.54 million +17.4%N/A7.2 $1.19
6/15/20247,550,000 shares $11.33 million -1.3%N/A5.2 $1.50
5/31/20247,650,000 shares $10.79 million +5.5%N/A5.3 $1.41
5/15/20247,250,000 shares $10.66 million +3.7%N/A4.7 $1.47
4/30/20246,990,000 shares $8.67 million +23.3%N/A4.6 $1.24
4/15/20245,670,000 shares $7.54 million +7.6%N/A4 $1.33
3/31/20245,270,000 shares $5.32 million +1.7%N/A3.6 $1.01
3/15/20245,180,000 shares $5.70 million +14.9%N/A3.7 $1.10
2/29/20244,510,000 shares $4.56 million +15.9%N/A4.2 $1.01
2/15/20243,890,000 shares $2.74 million +24.7%N/A3.7 $0.70
1/31/20243,120,000 shares $2.00 million -19.6%N/A3.1 $0.64
1/15/20243,880,000 shares $2.07 million -18.0%N/A4.3 $0.53
12/31/20234,730,000 shares $5.01 million +1.5%N/A4.9 $1.06
12/15/20234,660,000 shares $5.36 million +1.1%N/A6.3 $1.15
11/30/20234,610,000 shares $4.79 million +0.7%N/A7.3 $1.04
11/15/20234,580,000 shares $4.44 million +50.2%N/A8.7 $0.97
10/31/20233,050,000 shares $2.96 million +49.5%N/A6.6 $0.97
10/15/20232,040,000 shares $2.65 million +87.2%N/A6.5 $1.30
9/30/20231,090,000 shares $1.79 million +6.9%N/A7.7 $1.64
9/15/20231,020,000 shares $1.64 million -9.7%N/A8.1 $1.61
8/31/20231,130,000 shares $1.66 million No ChangeN/A8.9 $1.47
8/15/20231,130,000 shares $1.68 million -4.2%N/A8.7 $1.49
7/31/20231,180,000 shares $1.94 million +2.6%N/A8.2 $1.64
7/15/20231,150,000 shares $1.97 million -0.9%N/A7.4 $1.71
6/30/20231,160,000 shares $1.82 million +3.6%N/A6.8 $1.57
6/15/20231,120,000 shares $1.86 million -5.9%N/A5.4 $1.66
5/31/20231,190,000 shares $2.04 million -4.8%N/A4.8 $1.72
5/15/20231,250,000 shares $2.05 million +4.2%N/A2.7 $1.64
4/30/20231,200,000 shares $1.69 million +1.7%N/A2.6 $1.41
4/15/20231,180,000 shares $1.89 million +7.3%N/A2.6 $1.60
3/31/20231,100,000 shares $1.57 million -9.8%N/A2.4 $1.43
3/15/20231,220,000 shares $1.68 million -5.4%N/A3 $1.38
2/28/20231,290,000 shares $2.18 million +7.5%N/A3.5 $1.69
2/15/20231,200,000 shares $3.79 million +2.6%N/A4.1 $3.16
1/31/20231,170,000 shares $3.88 million -2.5%N/A4.5 $3.32
1/15/20231,200,000 shares $3.41 million -3.2%N/A3.6 $2.84
12/30/20221,240,000 shares $2.93 million +0.8%N/A3.3 $2.36
12/15/20221,230,000 shares $2.85 million +1.7%N/A3.4 $2.32
11/30/20221,210,000 shares $2.89 million +5.2%N/A3.3 $2.39
11/15/20221,150,000 shares $2.58 million +15.4%N/A3.3 $2.24
10/31/2022996,800 shares $4.67 million +21.3%N/A3.8 $4.68
10/15/2022822,000 shares $1.57 million -0.9%N/A4.5 $1.91
9/30/2022829,600 shares $1.68 million -0.7%N/A8.3 $2.02
9/15/2022835,100 shares $2.51 million +0.1%N/A7.8 $3.00
There’s a new type of capitalism (Ad)

The U.S. government has taken direct equity positions in at least 10 companies - Intel, U.S. Steel, Westinghouse, MP Materials, Lithium Americas, and others - plus roughly $2 billion in quantum computing investments. When these deals were announced, the stocks soared overnight. Porter Stansberry, founder of one of the world's largest financial research firms, says this shift away from free-market capitalism is the most consequential economic story in centuries - and almost no one is prepared for it. He's identified the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this new reality.tc pixel

See Porter Stansberry's full breakdown and investment recommendations now
8/31/2022834,400 shares $2.55 million -6.1%N/A7.1 $3.06
8/15/2022888,700 shares $2.88 million +5.9%N/A6.6 $3.24
7/31/2022838,900 shares $2.15 million -2.3%N/A5.4 $2.56
7/15/2022858,900 shares $2.16 million -4.1%N/A5.3 $2.52
6/30/2022895,600 shares $2.00 million -0.3%N/A4.7 $2.23
6/15/2022897,800 shares $2.22 million +6.0%N/A3 $2.47
5/31/2022847,000 shares $2.58 million -10.1%N/A3 $3.05
5/15/2022942,500 shares $2.51 million +8.6%N/A3.4 $2.66
4/30/2022867,800 shares $2.36 million -5.2%N/A3.5 $2.72
4/15/2022915,500 shares $3.22 million -8.5%N/A3.5 $3.52
3/31/20221,000,000 shares $6.68 million No ChangeN/A4 $6.68
3/15/20221,000,000 shares $5.38 million +1.2%N/A7.3 $5.38
2/28/2022988,000 shares $6.03 million -1.1%N/A7 $6.10
2/15/2022999,200 shares $6.48 million +1.3%N/A7.1 $6.49
1/31/2022986,700 shares $5.27 million +15.4%N/A5.8 $5.34
1/15/2022854,700 shares $4.73 million +10.0%N/A5.6 $5.53
12/31/2021776,800 shares $4.30 million -2.4%N/A5.1 $5.53
12/15/2021796,100 shares $5.10 million +9.6%N/A5.1 $6.40
11/30/2021726,200 shares $4.89 million +11.8%N/A4.4 $6.74
11/15/2021649,600 shares $4.85 million -3.5%N/A3.7 $7.47
10/29/2021672,900 shares $5.85 million -22.1%N/A3.7 $8.69
10/15/2021863,200 shares $7.62 million +4.1%N/A4.3 $8.83
9/30/2021829,200 shares $7.60 million +7.2%N/A3.6 $9.16
9/15/2021773,700 shares $7.78 million -14.2%N/A1.7 $10.05
8/31/2021901,200 shares $8.37 million -23.6%N/A1.8 $9.29
8/13/20211,180,000 shares $11.88 million No ChangeN/A2 $10.07
7/30/20211,180,000 shares $10.10 million +4.4%N/A2 $8.56
7/15/20211,130,000 shares $9.75 million +28.9%N/A1.9 $8.63
6/30/2021876,900 shares $9.73 million +27.3%N/A1.5 $11.10
6/15/2021688,900 shares $7.89 million -10.9%N/A1.4 $11.45

SLS Short Interest - Frequently Asked Questions

Short interest is the volume of SELLAS Life Sciences Group shares that have been sold short but have not yet been covered or closed out. As of May 29th, traders have sold 61,000,107 shares of SLS short. 31.43% of SELLAS Life Sciences Group's shares are currently sold short. Learn More on SELLAS Life Sciences Group's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLS shares currently have a short interest ratio of 4.4. Learn More on SELLAS Life Sciences Group's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 31.43% of SELLAS Life Sciences Group's floating shares are currently sold short.

SELLAS Life Sciences Group saw a increase in short interest in May. As of May 29th, there was short interest totaling 61,000,107 shares, an increase of 6.9% from the previous total of 57,070,692 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

31.43% of SELLAS Life Sciences Group's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to SELLAS Life Sciences Group: Immunovant, Inc. (9.53%), Kymera Therapeutics, Inc. (14.62%), Lantheus Holdings, Inc. (8.56%), Protagonist Therapeutics, Inc. (12.15%), Spyre Therapeutics, Inc. (17.25%), Mirum Pharmaceuticals, Inc. (11.74%), PTC Therapeutics, Inc. (13.62%), Rhythm Pharmaceuticals, Inc. (12.27%), Cogent Biosciences, Inc. (7.22%), Centessa Pharmaceuticals PLC Sponsored ADR (1.80%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling SLS is an investing strategy that aims to generate trading profit from SELLAS Life Sciences Group as its price is falling. SLS shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for SELLAS Life Sciences Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLS, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like SLS:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:SLS) was last updated on 6/12/2026 by MarketBeat.com Staff.
From Our Partners
Do NOT Buy SpaceX – Do This Instead
SpaceX is set to go public as soon as June 11, with OpenAI and Anthropic likely to follow. Whitney Tilson - Ha...
Stansberry Research | Sponsoredtc pixel
There’s a new type of capitalism
The U.S. government has taken direct equity positions in at least 10 companies - Intel, U.S. Steel, Westinghou...
Porter & Company | Sponsoredtc pixel
How to play the Biggest IPO in stock market history!
SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...
InvestPub | Sponsoredtc pixel
BUY THIS: Claim a backdoor stake in SpaceX
There may be a way to claim pre-IPO exposure to SpaceX before it ever hits public markets - using a simple tra...
Chaikin Analytics | Sponsoredtc pixel
Tesla. SolarCity. Twitter. This $4 stock is next.
Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity f...
Behind the Markets | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
One hidden supplier shipped 5 billion parts to SpaceX
Most investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...
Weiss Ratings | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel